['DRUG INTERACTIONS ASSOCIATED WITH INCREASED RISK OF MYOPATHY/RHABDOMYOLYSIS ( 2.3 5.1, 7 , 12.3 )', 'INTERACTING AGENTS', 'PRESCRIBING RECOMMENDATIONS', 'STRONG CYP3A INHIBITORS (E.G., ITRACONAZOLE, KETOCONAZOLE, POSACONAZOLE, VORICONAZOLE, CLARITHROMYCIN, TELITHROMYCIN, HIV PROTEASE INHIBITORS, BOCEPREVIR, TELAPREVIR, AND NEFAZODONE), ERYTHROMYCIN', 'CONTRAINDICATED WITH LOVASTATIN', 'GEMFIBROZIL, CYCLOSPORINE', 'AVOID WITH LOVASTATIN', 'DANAZOL, DILTIAZEM, DRONEDARONE, VERAPAMIL', 'DO NOT EXCEED 20 MG LOVASTATIN DAILY', 'AMIODARONE', 'DO NOT EXCEED 40 MG LOVASTATIN DAILY', 'GRAPEFRUIT JUICE', 'AVOID GRAPEFRUIT JUICE']